Zelira Therapeutics Dividenda 2025

Detalji o dividendama

Razumevanje dividendnih isplata od Zelira Therapeutics

Dividende od Zelira Therapeutics su deo profita kompanije koji se distribuira akcionarima. One su ključni indikator finansijskog zdravlja kompanije i atraktivnosti za investitore. Dividende pružaju investitorima stabilan izvor prihoda, pored dobiti koja se možda može ostvariti prodajom akcija po višoj ceni od kupovne.

Poređenje iz godine u godinu

Analiza isplata dividendi od Zelira Therapeutics tokom godina može istaći profitabilnost i stabilnost kompanije. Konstantno ili rastuće isplate dividendi mogu ukazivati na finansijski zdravu kompaniju sa predvidivim profitom, dok fluktuacije ili smanjenja dividendi mogu signalizirati osnovne finansijske ili operativne izazove.

Uticaj na investicije

Isplate dividendi od Zelira Therapeutics su suštinski faktor za investitore orijentisane na prihod. Robusna isplata dividendi može povećati privlačnost akcije i pružiti redovni prihod pored potencijalnih kapitalnih dobitaka. Ona može takođe pokazati poverenje kompanije u njene buduće profite i time biti značajan faktor za odlučivanje o investicijama.

Interpretacija fluktuacija dividendi

Promene u dividendama od Zelira Therapeutics mogu proistići iz promena u profitima kompanije, finansijskoj politici ili strategijama reinvestiranja. Povećanje dividendi često signalizira finansijsku stabilnost, dok smanjenje može ukazivati na potrebu da se sačuva gotovina ili da se profiti reinvestiraju radi podsticanja rasta, pri čemu svaki scenario ima različite posledice za investitore.

Zelira Therapeutics Aktienanalyse

Шта ради Zelira Therapeutics?

Zelira Therapeutics was founded in 2016 with its headquarters in Perth, Australia. The company focuses on the development, production, and marketing of medical cannabis to meet the needs of patients worldwide. The company's business model is based on producing medical cannabis specifically tailored to patients' needs. It works closely with doctors and patients to ensure its products are effective and meet patients' needs. Zelira Therapeutics operates in three main areas. The first is the development of products for treating pain and inflammation in chronic conditions such as multiple sclerosis, cancer, and epilepsy. The second area includes the development of products for treating sleep disorders. The third area is the development of products for treating mental disorders such as anxiety and depression. The company has developed a wide range of products, including oils, pills, sprays, and topical creams. An example of a product is the ZTL-101 oil, which was developed for treating pain and inflammation in patients with osteoarthritis. The oil contains a combination of CBD and THC. The company has also partnered with the University of Mississippi to research the use of medical cannabis for treating post-traumatic stress disorder (PTSD). The research is funded by the US government and aims to legitimize the use of medical cannabis for treating PTSD. Zelira Therapeutics has also formed partnerships with other companies and organizations to advance its research and development. In 2020, the company entered into an agreement with Emerald Health Therapeutics, a Canadian company specializing in the production of medical cannabis. The two companies will collaborate on developing products for treating sleep disorders. The company has also partnered with iCAN Israel-Cannabis, an Israel-based company specializing in the research and development of medical cannabis. The two companies are working together to develop new products and promote the use of medical cannabis in various countries. In addition to its partnerships, Zelira Therapeutics has established a strong presence in various international markets. It is currently operating in the US, Australia, New Zealand, and Germany, and is working to expand into other countries. Overall, Zelira Therapeutics is a company specializing in the development of medical cannabis for treating various conditions. It has a wide range of products and works closely with doctors and patients to ensure their effectiveness and meet patients' needs. With strong partnerships and a presence in various international markets, the company has a promising future. Zelira Therapeutics je jedna od najpopularnijih kompanija na Eulerpool.com.

Često postavljana pitanja o Zelira Therapeutics akciji

Kolika je dividenda koju isplaćuje Zelira Therapeutics?

U poslednjih 12 meseci, Zelira Therapeutics je isplatio dividendu u iznosu od . To odgovara dividendnom prinosu od oko . Za narednih 12 meseci, Zelira Therapeutics će verovatno isplatiti dividendu od 0 AUD.

Kolika je dividendna prinosa za Zelira Therapeutics?

Dividendski prinos od Zelira Therapeutics trenutno iznosi .

Kada Zelira Therapeutics isplaćuje dividendu?

Zelira Therapeutics isplaćuje dividende na kvartalnom nivou. One se isplaćuju u mesecima .

Koliko je sigurna dividenda od Zelira Therapeutics?

Zelira Therapeutics je isplaćivao dividendu svake godine u poslednjih 0 godina.

Kolika je dividenda kompanije Zelira Therapeutics?

Za narednih 12 meseci očekuju se dividende u iznosu od 0 AUD. To odgovara dividendnom prinosu od 0 %.

U kom sektoru se nalazi Zelira Therapeutics?

Zelira Therapeutics se svrstava u sektor 'Zdravlje'.

Wann musste ich die Aktien von Zelira Therapeutics kaufen, um die vorherige Dividende zu erhalten?

Da biste primili poslednju dividendu od Zelira Therapeutics od 20. 1. 2025. u iznosu od 0 AUD, morali ste da imate akciju u depou pre Ex-dana 20. 1. 2025..

Kada je Zelira Therapeutics poslednji put isplatio dividendu?

Isplata poslednje dividende izvršena je 20. 1. 2025..

Kolika je bila dividenda od Zelira Therapeutics u godini 2024?

U godini 2024 kompanija Zelira Therapeutics je isplatila 0 AUD kao dividende.

U kojoj valuti Zelira Therapeutics isplaćuje dividendu?

Dividende od Zelira Therapeutics se isplaćuju u AUD.